D.C. Circuit: HHS Drug Price Disclosure Rule Runs Afoul Of APA

Mealey's (June 19, 2020, 1:13 PM EDT) -- WASHINGTON, D.C. — The District of Columbia U.S. Circuit Court of Appeals on June 16 concluded that “there is no reasoned statutory basis” for a May 2019 rule by the U.S....
To view the full article, register now.